InsidersTradesSigma
Follow the ARS Pharmaceuticals, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €782.5m. The latest transaction was reported on 12 June 2026 (Cession). Among the most active insiders: Lowenthal Richard E. Every trade is openly available.
130
Insider Decl.
n/a
Thresholds
€38m
7 ops.
Buy Volume
€45m
67 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ARS Pharmaceuticals, Inc. Strong Buy (bullish), based on 4 analysts. Average price target: US$26.75.
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,538 of 28,547 companies
25.9
score / 100
Value7
Quality45
FCF yld-30%
Earn yld-30%
EV/EBITDA·
ROE-210%
Gross mgn76%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 June 2026
Declarations130 total
3,355 sharesCommon StockSEC:0001398595-26-000004:0
25,000 sharesCommon StockSEC:0001951287-26-000004:0
25,000 sharesCommon StockSEC:0001951287-26-000004:1
30,000 shares@ US$0.84Common StockSEC:0001951238-25-000005:0
250,000 shares0Common StockSEC:0001580787-25-000004:0
21,828 shares@ US$0.64Common StockSEC:0001380762-25-000005:0
50,000 shares@ US$14.48696.5% of flowCommon StockSEC:0001415889-25-022761:0
12,500 shares@ US$1.509.7% of flowCommon StockSEC:0001415889-25-022760:0
12,344 shares@ US$14.02541.6% of flowCommon StockSEC:0001415889-25-022638:0
15,000 shares@ US$1.5022.5% of flowCommon StockSEC:0001415889-25-019321:0
370,075 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:0
370,074 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:1
15,000 shares@ US$1.5029.9% of flowCommon StockSEC:0001415889-25-017901:0
100,000 shares@ US$5.5878.3% of flowCommon StockSEC:0001415889-25-014186:0
120,000 shares@ US$1.01100.0% of flowCommon StockSEC:0001415889-25-014185:0
50,000 shares@ US$1.5044.2% of flowCommon StockSEC:0001415889-25-014184:0
22,509 shares@ US$4.852.8% of flowCommon StockSEC:0001415889-25-010395:0
27,493 shares@ US$4.853.4% of flowCommon StockSEC:0001415889-25-010395:1
50,002 shares@ US$12.30115.7% of flowCommon StockSEC:0001415889-25-010395:2
10,000 shares@ US$1.5029.8% of flowCommon StockSEC:0001415889-25-008796:0
400 shares@ US$4.850.1% of flowCommon StockSEC:0001415889-25-007438:0
9,064 shares@ US$3.150.8% of flowCommon StockSEC:0001415889-25-002955:0
40,936 shares@ US$4.855.4% of flowCommon StockSEC:0001415889-25-002955:1
50,000 shares@ US$12.311316.7% of flowCommon StockSEC:0001415889-25-002955:2
50,000 shares@ US$3.154.3% of flowCommon StockSEC:0001415889-25-001053:0
25 of 130 declarations
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. is a company focused on developing treatments for allergies and respiratory diseases. It is listed on NASDAQ under the ticker ARS.